Background: Sequence variants located at 15q25 have been associated with lung cancer and propensity to smoke. We recently reported an association between rs16969968 and risk of upper aerodigestive tract (UADT) cancers (oral cavity, oropharynx, hypopharynx, larynx, and esophagus) in women (OR ¼ 1.24, P ¼ 0.003) with little effect in men (OR ¼ 1.04, P ¼ 0.35).
Introduction
Exposure to alcohol and tobacco are the major risk factors for upper aerodigestive tract (UADT) cancers (cancers of the oral cavity, oropharynx, hypopharynx, larynx, and esophagus) in Europe and America (1) .
Common genetic variants located at chromosome 15q25, a locus that contains 3 genes that encode nicotinic acetylcholine receptor (nAChR) subunits (CHRNA5, CHRNA3, and CHRNB4), have been implicated in the risk of lung cancer, chronic obstructive pulmonary disease (COPD) and peripheral arterial disease (2) (3) (4) (5) . The same variants are associated with increased propensity to smoke tobacco (4, 6, 7) , leading to the hypothesis that this might explain the associations noted with pathologies linked to tobacco exposure (4, 8) . Others have suggested that these variants may have additional independent effects (2, 5, (9) (10) (11) . In a recent study of 3,968 UADT cancer cases and 5,319 controls (10), we observed that there was statistically significant association between 15q25 variant rs16969968 and risk of UADT cancers in women (OR ¼ 1.24, 95% CI ¼ 1.08-1.42, P ¼ 0.003) but not men [OR ¼ 1.04, 95% CI ¼ 0.96-1.12, P ¼ 0.35; P-heterogeneity (P het ) ¼ 0.03].
In the present study, we sought to validate these findings in an independent series of 4,604 UADT cancer cases and 6,239 controls from 10 UADT cancer case-control studies participating in the International Head and Neck Cancer Epidemiology (INHANCE) consortium (12) .
Materials and Methods

Study subjects
Ten independent case-control studies of UADT cancers from INHANCE consortium (7 were conducted in America and 3 in Europe) participated in our present study. Study designs and population characteristics have been described in more detail previously (12) (13) (14) (15) and are briefly described in Table 1 and Supplementary Table S1 . All the subjects included in the pooled analysis were of self-reported European ancestry. As previously described (12) , all INHANCE studies have extensive information on tumor site and histology, as well as lifestyle characteristics. The majority of hospital-based studies excluded controls with tobacco-related pathologies as a control source (13) (14) (15) . The exceptions were the Penn State, Rome, MD Anderson, and Pittsburgh studies that did not exclude tobacco-related pathologies specifically. Written informed consent was obtained from all study subjects and studies were approved by the Institutional Review Boards at each study center. Analysis was restricted to squamous cell carcinomas.
Genotyping and quality control
Genotyping of the 15q25 variant, rs16969968, was carried out in 8 genotyping laboratories (Supplementary  Table S1 ) using the TaqMan genotyping platform (rs16969968 Taqman assay primers GAGTGGTAGTG-GACCAAAATCTTCT and ACCTCACGGACAT-CATTTTCCTT probes VIC-MGB-CTGCGCTCAATTC, FAM-MGB-CTGCGCTCGATTC). A common series of 90 standard DNAs were genotyped at each laboratory to ensure the quality and comparability of the genotyping results across the different studies. The overall concordance with the consensus genotype and the genotypes from the 8 laboratories for the standardized DNAs was 99.86%. Genotype success rate was greater than 95.87% across each site and genotype distributions were consistent with that expected by Hardy-Weinberg equilibrium (HWE).
Statistical analysis
The association between rs16969968 and UADT cancer risk was estimated by ORs and 95% CIs per allele (under log-additive model) and genotype derived from multivariate unconditional logistic regression, with age, sex, and study site (or country when appropriate) included in the model as covariates. Heterogeneity of ORs was assessed using the Cochran's Q test. The association between the rs16969968 variant allele and number of cigarettes smoked per day (CPD) was carried out in ever smokers using multivariate linear regression on logtransformed data. Mean values and 95% CIs were calculated in the combined initial and present data sets with adjustment for age, sex, and study site (and case-control status when appropriate). Differential effect of this single nucleotide polymorphism (SNP) on CPD between sexes was evaluated in a linear regression analysis by including a genotype by sex interaction term.
Results
In the independent series of 4,604 UADT cancer cases and 6,239 controls, the association between rs16969968 and UADT cancers was found in women (OR ¼ 1.21, 95% CI ¼ 1.08-1.36, P ¼ 0.001), with little evidence for association in men (OR ¼ 1.02, 95% CI ¼ 0.95-1.09, P ¼ 0.66; P het ¼ 0.01; Fig. 1 ). This is consistent with the observation in the initial study (OR ¼ 1.24, 95% CI ¼ 1.08-1.42 for women; OR ¼ 1.04, 95% CI ¼ 0.96-1.12 for men; P het ¼ 0.03; ref. 10). To further evaluate this genetic effect, we pooled individual level data from the initial study and the 10 independent studies presented here, making for a total of 8,572 UADT cancer cases and 11,558 controls from 14 studies. We then conducted stratified analysis in both women and men ( Fig. 1 ). In the combined series, rs16969968 was associated with UADT cancers only in females (females: OR ¼ 1.22, 95% CI ¼ 1.12-1.34, P ¼ 7 Â 10 À6 ; males: OR ¼ 1.02, 95% CI ¼ 0.97-1.08, P ¼ 0.35; P het ¼ 6 Â 10 À4 ). In women, the association of rs16969968 with UADT cancer risk was relatively consistent among subgroups stratified by smoking status, alcohol consumption, and age. Significant heterogeneity was noted by UADT cancer subsite (P het ¼ 0.02), with the association strongest among female laryngeal cancer (OR ¼ 1.40, 95% CI ¼ 1.21-1.61, P ¼ 6 Â 10
À6
) and absent in female cancers of the oropharynx (OR ¼ 1.00, 95% CI ¼ 0.84-1.18, P ¼ 0.97) and hypopharynx (OR ¼ 0.95, 95% CI ¼ 0.63-1.43, P ¼ 0.80). Evidence for association was also present in female never smokers (OR ¼ 1.18, 95% CI ¼ 1.00-1.39, P ¼ 0.05) and never drinkers (OR ¼ 1.35, 95% CI ¼ 1.14-
). In contrast, in men there was little evidence for association between rs16969968 and UADT cancers in any stratum.
The rs16969968 variant has been consistently associated with propensity to smoke cigarettes (particularly CPD; refs. 4, 6, 7), we therefore examined whether rs16969968 was associated with CPD among 11,991 ever smokers included in the combined initial and present data sets, as well as in UADT cancer cases and controls separately and among males and females (Table 2 ). In the combined series, the rs16969968 minor allele was Forest plots representing the association between rs16969968 and UADT cancer risk in women, men, and the combined series, respectively. Unless specified, the ORs and 95% CIs were derived from the log-additive genetic model with adjustment for age, study site, and sex when appropriate. , with rare homozygotes ever smoking carriers smoking 1.72 CPD more than common homozygotes. There was little evidence for a sex difference in the effect of the rs16969968 variant on CPD, with male and female smoking variant carriers smoking approximately the same amount more (male and female rare homozygotes smoked 1.79 and 1.29 CPD more than common homozygotes, respectively; P het ¼ 0.86; Table 2 ). Similar patterns were observed in cases and controls when analyzed separately (P het ¼ 0.51 and 0.99, respectively).
Discussion
This study has replicated our previous observation of a sex difference in the association between the 15q25 variant rs16969968 and UADT cancers. In a combined analysis, the association was highly significant in women (P ¼ 7 Â 10 À6 ) but not men (P ¼ 0.35) with strong evidence for heterogeneity (P het ¼ 10 À4 ) arguing against a chance finding. Under the hypothesis that the association between the rs16969968 variant and tobacco-related pathologies is mediated by this variant's effect on propensity to smoke, an association in UADT cancers, and particularly in laryngeal cancers, would be expected. However, the observation of a sex difference in the association with UADT cancers is intriguing for several reasons. Firstly, extrapolating from the observed effect of rs16969968 on CPD, only a small OR of approximately 1.02 for UADT cancers is expected in both men and women (Supplementary Method and Supplementary  Table S2 ). This corresponds closely with observation of association between UADT cancers and rs16969968 in men but risk observed in women is much higher. Secondly, as reported here (Table 2) and elsewhere (4, 6) , there is little evidence for a sex difference in the association between rs16969968 and CPD. This association could be potentially caused by a sex difference in the association between the 15q25 variant and smoking propensity not captured by the crude smoking measures available to this study. Nevertheless, if this association was caused by such a sex difference in propensity to smoke, one might expect the sex difference in this association to manifest more strongly in a cancer such as lung cancer, where the risks associated with tobacco consumption are more pronounced. However, to date, there is only inconsistent evidence for a sex difference in the association between this 15q25 variant and lung cancer (9) (10) (11) . This seems to imply that rs16969968 has additional effects on UADT cancer susceptibility than just increasing propensity to smoke, as has been suggested for lung cancer (2, (9) (10) (11) .
nAChRs are expressed throughout the UADT and have been shown to mediate pathobiological effects of tobacco and nicotine derivatives in the stratified epithelium lining the upper digestive tract (16) (17) (18) (19) . The rs16969968 SNP causes a change in amino acid 398 from asparagine (encoded by the G allele) to aspartic acid (encoded by A allele) in the second intracellular loop of the a5 subunit, and there is some evidence to suggest that this change alters nAChR function in response to nicotine agonist in vitro (20) . However, the functional consequences of this alteration in UADT carcinogenesis remain to be established. In our study, the strongest association with 15q25 variant was observed among female laryngeal cancer. The male-to-female ratio in laryngeal cancer is 4.7:1 in America (21) and 11.3:1 in Europe (22), one of the highest among all cancer sites. It is worth noting that the difference in susceptibility to larynx cancer based on gender has remained unchanged through the years despite the increasing tobacco and alcohol consumption among women. The larynx is influenced by sexual hormones during the fetal development, as well as puberty and adulthood as it is subject to laryngeal epithelial layer modifications, cartilage metaplasia, and morphostructural changes (23, 24) . These considerations, in association with the epidemiologic evidence, have led to the speculation that sex hormones might be involved in the carcinogenesis process (25) . Our finding of sex-specific effect of 15q25 variant may add to the knowledge in understanding the underlying mechanism of sex difference in susceptibility to laryngeal cancer. Although speculative, there has been some data linking nAChR signaling to sex hormones. For example, some studies have shown that steroid hormones, including progesterone, are noncompetitive antagonists of nAChR (26, 27) . In addition, a putative progesterone responsive element was found to be present in the promoter of a5 nAChR subunit, and progesterone has been shown to have an effect on a5 expression level both in vitro and in vivo (28) . It is biologically plausible that the interplay between sex hormones and a5-containing nAChR may play a direct or indirect role in mediation of sex difference in susceptibility to laryngeal cancer. Nevertheless, such speculation needs to be further tested in in-depth molecular mechanistic studies in the future.
Several limitations are present in this pooled study. First, the observed sex-specific association could potentially be caused by a difference in variant frequency in controls between sexes (e.g., caused by, population stratification or a sex-specific ascertainment bias due to pathology type in hospital-based studies). However, there was little difference in the frequency of rs16969968 variant between male and female controls in any of the studies (Supplementary Table S3 ). Second, the information on human papillomavirus (HPV) infection, involved in the etiology of UADT cancers, particularly orophayrngeal cancers (29) , was not available in our study. Interestingly, there was little evidence for an association between 15q25 variant and oropharyngeal cancer. Further studies including HPV infection status may help to clarify whether the effect of 15q25 variant are different in HPV-positive and HPV-negative oropharyngeal cancers.
In summary, this study has replicated the association between 15q25 variant rs16969968 and risk of UADT cancers in women, particularly prominent for laryngeal cancer. By contrast, there is little effect in men, implying a sex-specific effect. The biological basis for this association remains unclear and additional study appears warranted to further validate and explore these findings.
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